Immune checkpoint inhibitor‐related cholangiopathy: Novel clinicopathological description of a multi‐centre cohort-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint inhibitor‐related cholangiopathy: Novel clinicopathological description of a multi‐centre cohort

Published:2022-06-23 Issue:1 Volume:43 Page:147-154
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Berry Philip¹,Kotha Sreelakshmi¹^ORCID,Zen Yoh²,Papa Sophie³,El Menabawey Tareq⁴,Webster George⁴,Joshi Deepak⁵,Heneghan Michael⁵

Affiliation:

1. Department of Hepatology Guy's and St Thomas' Foundation Trust London UK

2. Department of Histopathology King's College Hospital London UK

3. Department of Oncology Guy's and St Thomas' Foundation Trust London UK

4. Department of hepato‐biliary medicine University college London Hospital London UK

5. Department of Hepatology King's college Hospital London UK

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15340

Reference33 articles.

1. Pointed Progress in Second-Line Advanced Non–Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition

2. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

3. Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors

4. Risk of Liver Toxicity with Nivolumab Immunotherapy in Cancer Patients

5. Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatobiliary complications of immune checkpoint inhibitors in cancer;Exploration of Targeted Anti-tumor Therapy;2024-07-26

2. Immune checkpoint inhibitor-induced cholangitis—a three-case series;Exploration of Targeted Anti-tumor Therapy;2024-07-19

3. Clinical features, treatment, and outcome of pembrolizumab induced cholangitis;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-15

4. Management of sotorasib-related adverse events and hepatotoxicities following anti-PD-(L)1 therapy: Experience with sotorasib in two French anti-cancer centers and practical guidance proposal;Lung Cancer;2024-05

5. Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors;Alimentary Pharmacology & Therapeutics;2024-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3